Page 185 Acute Pain Management
P. 185




In
patients
having
hand
surgery,
IVRA
using
a
combination
of
lignocaine
and
dexamethasone

resulted
in
lower
pain
scores
and
lower
analgesic
requirements
for
24
hours
compared
with

lignocaine
alone
or
lignocaine
IVRA
with
dexamethasone
in
the
non‐operative
arm
(Bigat
et
al,

2006
Level
II).

The
addition
of
dexamethasone
to
lignocaine
for
axillary
brachial
plexus
block
prolonged
the

duration
of
sensory
and
motor
blockade
compared
with
lignocaine
alone
(Movafegh
et
al,
2006

Level
II).

There
is
insufficient
evidence
to
support
the
use
of
injection
therapy,
including
corticosteroids,

in
subacute
and
chronic
low‐back
pain.
However,
it
cannot
be
ruled
out
that
specific

subgroups
of
patients
may
respond
to
a
specific
type
of
injection
therapy
(Staal
et
al,
2009

Level
I).
Lumbar
epidural
steroid
injections
may
provide
short‐term
relief
from
acute
radicular

pain
but
did
not
impact
on
function,
need
for
surgery,
or
provide
long‐term
pain
relief
beyond

3
months
(Armon
et
al,
2007
Level
I).

Topical
Topical
corticosteroids
have
not
been
shown
to
have
consistent
efficacy
in
acute
herpes
zoster

(Hempenstall
et
al,
2005
Level
I).


Key
messages

1.
 Subacromial
injections
of
corticosteroids
are
superior
to
oral
NSAIDs
in
treating
rotator
cuff

tendonitis
(N)
(Level
I).

2.
 Lumbar
epidural
steroid
administration
is
effective
for
short
‐term
relief
of
acute
radicular

pain
(N)
(Level
I).

3.
 Following
knee
joint
arthroscopy,
intra‐articular
steroids
in
combination
with
either
local
 CHAPTER
5

anaesthetic
or
opioids
reduce
pain,
analgesic
consumption
and
duration
of
immobilisation

(N)
(Level
II).

4.
 Intravenous
regional
anaesthesia
combining
dexamethasone
with
lignocaine
improves

analgesia
for
up
to
24
hours
(N)
(Level
II).

5.
 There
is
a
risk
of
septic
arthritis
with
intra‐articular
steroids
(N)
(Level
IV).

5.4.2 Non-steroidal anti-inflammatory drugs

Peripheral sites
Intra‐articular
nsNSAIDs
such
as
tenoxicam
and
ketorolac
resulted
in
improved
pain
relief
after

surgery
(Elhakim
et
al,
1996
Level
II;
Cook
et
al,
1997
Level
II;
Convery
et
al,
1998
Level
II;
Colbert
et
al,

1999
Level
II;
Gupta
et
al,
1999
Level
II);
no
long‐term
follow‐up
looking
at
any
effect
on
bone

healing
has
been
undertaken.

Topical
With
topical
application
of
diclofenac,
tissue
levels
are
higher
and
plasma
levels
lower
than

following
oral
administration
(Zacher
et
al,
2008).
Topical
diclofenac
significantly
reduced
pain

and
inflammation
in
a
range
of
sports,
traumatic
and
inflammatory
acute
and
chronic

conditions
compared
with
placebo
and
was
comparable
to
other
topical
NSAIDs
(although

there
were
no
direct
comparisons)
and
oral
diclofenac,
ibuprofen
and
naproxen.
(Zacher
et
al,

2008
Level
I).
Topical
ketoprofen
used
for
up
to
one
week
in
acute
painful
conditions
(strains,

sprains
or
sports
injuries)
had
a
NNT
of
3.8,
which
was
significantly
better
than
other
topical

NSAIDs,
although
in
non‐comparative
(head‐to‐head)
trials.
(Mason
et
al,
2004
Level
I).
Topical

indomethacin
did
not
have
proven
efficacy
(Moore
RA
et
al,
1998
Level
I).



 Acute
pain
management:
scientific
evidence
 137

   180   181   182   183   184   185   186   187   188   189   190